Clinical Trial on Ullilehyam (Folkflore Medicine) And Gudanagarahareetaki Granules in the Management of Artavakshaya (Oligomenorrhea)

Randomized Clinical Trial on Ullilehyam (Folkflore Medicine) And Gudanagarahareetaki Granules in the Management of Artavakshaya (Oligomenorrhea) - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073533

Enrollment

Registered

2024-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: married or unmarried women with features of oligomenorrhgea and artavakshaya with or without PCOS,hypothyroidism with oligomenorrhea,

Exclusion criteria

Exclusion criteria: 1. Patients suffering from systesnic diseases like Uncontrolled diabetes, Peptic ulcer diseases. IBS, Chronic Renal diseases, Hepatic diseases, Cardiac disorders. Tuberculosis, Coagulopathy. Women having systemic diseases which interfere with the present study. 2. Pituitary and Hypothalamic abnormalities. 3. Hyperthyroidism. Thyrotoxicosis. Ultrasonography showing Congenital or Acquired anatomical defects, Pelvic pathology like uterine myoma. 5. HIV/HBsAg positive 6. Tubercular endometritis. 7. Endometrial/cervical/Breast carcinoma any malignant diseases. Females using oral contraceptive pills, IUCD, injectabile contraceptives. 9. Pregnant and Lactating mother

Design outcomes

Primary

Measure	Time frame
assessed based on subjective and objective parameters Subjective Parameters Pain in lower abdomen and vagina Interval between two cycles Duration of menstrual cycle Amount of bleeding (no. of pads/day) Objective parameters Ultrasonography either TAS/TVS Basal body temperature Cervical mucosa evaluation Follicular study (if done) Amount of bleeding (number of pads per dayTimepoint: 1st 5th 12th 14th and 16th day (if necessary) of one menstrual cycle after treatment	—

Measure

Time frame

assessed based on subjective and objective parameters Subjective Parameters Pain in lower abdomen and vagina Interval between two cycles Duration of menstrual cycle Amount of bleeding (no. of pads/day) Objective parameters Ultrasonography either TAS/TVS Basal body temperature Cervical mucosa evaluation Follicular study (if done) Amount of bleeding (number of pads per dayTimepoint: 1st 5th 12th 14th and 16th day (if necessary) of one menstrual cycle after treatment

—

Secondary

Measure	Time frame
assessed based on subjective & objective parameters Subjective Parameters Pain in lower abdomen & vagina Interval between two cycles Duration of menstrual cycle. Amount of bleeding (no. of pads/day) Objective parameters Ultrasonography either TAS/TVS Basal body temperature Cervical mucosal evaluation Follicular study (if done) Amount of bleeding (number of pads per dayTimepoint: 1st 5th 12th 14th of each menstrual cycle before during treatment	—

Measure

Time frame

assessed based on subjective & objective parameters Subjective Parameters Pain in lower abdomen & vagina Interval between two cycles Duration of menstrual cycle. Amount of bleeding (no. of pads/day) Objective parameters Ultrasonography either TAS/TVS Basal body temperature Cervical mucosal evaluation Follicular study (if done) Amount of bleeding (number of pads per dayTimepoint: 1st 5th 12th 14th of each menstrual cycle before during treatment

—

Countries

India

Contacts

Public ContactDr Asokan V

Alvas Ayurveda Medical College

drasokan24@gmail.com9008838531

Outcome results